The heads of countless hemagglutinin proteins are arrayed on the surface portion of the virus along with another ...

Two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), and the M2 ion-channel protein are embedded in the viral envelope, which is derived from the host's plasma membrane.

While current influenza vaccines primarily target the variable hemagglutinin protein, the slower-evolving neuraminidase presents a promising target for the development of new vaccines providing ...

The virus attaches itself to receptors on the cell surface using a protein called hemagglutinin (HA). To a lesser extent, the virus can also use another protein called neuraminidase (NA).

In the study, scientists describe a process they've developed for creating doses with precise amounts of two key proteins—hemagglutinin (H5) and neuraminidase (N1)—that prompt the body's ...

Influenza A viruses are classified into different subtypes based on their surface glycoproteins, hemagglutinin (H) and neuraminidase (N). A total of 15 subtypes of hemagglutinin (i.e., H1–H15 ...

which allow a more granular view of the hemagglutinin and neuraminidase genes, or even the entire genome.NGS can provide insight, including characterization of mixed populations. Genome ...

In the study, scientists describe a process they’ve developed for creating doses with precise amounts of two key proteins – hemagglutinin (H5) and neuraminidase (N1) – that prompt the body’s immune ...

In the study, scientists describe a process they've developed for creating doses with precise amounts of two key proteins – hemagglutinin (H5) and neuraminidase (N1) – that prompt the body's ...

When the Imaging system is paired with the Influenza Seasonal Hemagglutinin potency assay kit, it creates a semi-automated platform to rapidly perform singleplex and multiplex immunoassays for ...

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...

In the study, scientists describe a process they’ve developed for creating doses with precise amounts of two key proteins — hemagglutinin (H5) and neuraminidase (N1) — that prompt the body’s immune ...